Clinical trial
Gemcitabine in Treating Patients With Advanced Colorectal Cancer
NCT00007943 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00007943 |
|---|---|
| Title | Gemcitabine in Treating Patients With Advanced Colorectal Cancer |
| Official title | A Phase II Study Of Twenty-Four Hour Infusion Gemcitabine For Advanced Colorectal Cancer |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride |
| Enrollment | 15 |
| Start date | Sep 1, 2000 |
| Primary completion | Feb 27, 2001 |
| Completion | Feb 27, 2001 |
| First posted | Apr 13, 2004 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: